European stocks rose, lifted by Novo Nordisk A/S shares after a US competitor scrapped a copycat Wegovy weight-loss pill. The Stoxx Europe 600 Index was up 0.4% as of 8:26 am in London. In individual stocks, Novo Nordisk rose 8.6% after US firm Hims & Hers Health Inc. said it will stop selling a cheaper…
Denmark-based pharmaceutical giant, Novo Nordisk, stock surged more than 8% during the intraday trading session on Monday, 9 February 2026, after rival healthcare firm Hims & Hers withdrew its knockoff weight-loss drug from the market amid US Food and Drug Administration (FDA) scrutiny. Novo Nordisk stock jumped 8.6% to 321 Danish Krone (kr) during the…
(Bloomberg) — European stocks turned higher in a volatile Friday session as a rebound in drugmaker Novo Nordisk A/S helped counter weakness in carmakers. The Stoxx Europe 600 Index rose 0.9% by the close. Novo jumped 5.3% after having lost as much as a quarter of its market value during the week over concerns about…
European stocks fell as sentiment took a hit from weak US jobs data, with investors also tracking a busy slate of earnings and key interest-rate decisions. Novo Nordisk A/S dropped as a US competitor plans to offer cheaper copies of its new weight loss pill. The Stoxx Europe 600 Index fell 1% at the close….
